Brown Brothers Harriman & Co’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Brown Brothers Harriman & Co’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-948	Closed	-$38.5K	–	1765
2025 Q2	$38.5K	Hold	948	–	–	﹤0.01%	983
2025 Q1	$41.5K	Buy	+948	New	+$41.8K	﹤0.01%	858

Other funds holding XPH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $18.1B AUM 15% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Brown Brothers Harriman & Co's XPH Position: Q3 2025 in Review

Brown Brothers Harriman & Co sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2025, closing a stake of 948 shares — an estimated $38.5K sold.

Brown Brothers Harriman & Co first reported a position in XPH in Q1 2025 and held it in 2 quarters. The position peaked at $41.5K in Q1 2025. 69 funds tracked by Wall St. Rank hold XPH as of Q3 2025.

Brown Brothers Harriman & Co reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2025 after selling out during the quarter.
Brown Brothers Harriman & Co sold 948 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2025, an estimated $38.5K.
Brown Brothers Harriman & Co first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2025 and held it in 2 quarters.
Brown Brothers Harriman & Co's State Street SPDR S&P Pharmaceuticals ETF position peaked at $41.5K in Q1 2025.
69 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2025.

Based on Brown Brothers Harriman & Co's 13F filing for Q3 2025, filed 13 Nov 2025.